Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03509350 · ClinicalTrials.gov registry record · Phase 3
Vitamin C, Thiamine, and Steroids in Sepsis
A Phase 3 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 3
- Development phase
- 501
- Enrollment target
NCT03509350 is a Phase 3 study that has completed, run by Emory University. The registered enrollment target is 501 participants.
The verdict
NCT03509350, a Phase 3 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 501 participants
- Enrollment target
Study Summary
The VItamin C, Thiamine And Steroids in Sepsis (VICTAS) Study is a double-blind, placebo-controlled, adaptive randomized clinical trial designed to investigate the efficacy of the combined use of vitamin C, thiamine and corticosteroids versus indistinguishable placebos for patients with sepsis. The objective of this study is to demonstrate the efficacy of combination therapy using vitamin C, thiamine and corticosteroids in reducing mortality and improving organ function in critically ill patients with sepsis.
Interventions
- DRUG Thiamine
- DRUG Vitamin C
- DRUG Hydrocortisone
- DRUG Vitamin C Placebo
- DRUG Thiamine Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 501 participants |
| Start Date | 2018-08-22 |
| Est. Completion | 2020-01-29 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03509350
The ClinicalTrials.gov registry entry for NCT03509350 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 501 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Thiamine is the first listed.
NCT03509350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03509350 about?
NCT03509350 is a clinical study titled "Vitamin C, Thiamine, and Steroids in Sepsis". The VItamin C, Thiamine And Steroids in Sepsis (VICTAS) Study is a double-blind, placebo-controlled, adaptive randomized clinical trial designed to investigate the efficacy of the combined use of vitamin C, thiamine and corticosteroids versus indistinguishable placebos for patients with sepsis. The ...
What is the current status of trial NCT03509350?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 501 participants. The study started on 2018-08-22. Estimated completion is 2020-01-29.
What interventions are being tested in trial NCT03509350?
The interventions under investigation include: Thiamine (DRUG), Vitamin C (DRUG), Hydrocortisone (DRUG), Vitamin C Placebo (DRUG), Thiamine Placebo (DRUG).
Who is sponsoring clinical trial NCT03509350?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.